| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 27.238 | 33.008 | 81.388 | 139.465 |
| Total Income - EUR | - | - | - | - | - | - | 27.238 | 33.008 | 81.388 | 139.495 |
| Total Expenses - EUR | - | - | - | - | - | - | 12.914 | 29.101 | 34.700 | 60.327 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 14.325 | 3.907 | 46.689 | 79.168 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 14.058 | 3.583 | 45.915 | 76.121 |
| Employees | - | - | - | - | - | - | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Qualis Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 1.994 | 2.111 | 3.042 | 41.163 |
| Current Assets | - | - | - | - | - | - | 13.041 | 5.085 | 49.557 | 115.163 |
| Inventories | - | - | - | - | - | - | 729 | 533 | 1.515 | 0 |
| Receivables | - | - | - | - | - | - | 8.008 | 3.669 | 45.697 | 98.300 |
| Cash | - | - | - | - | - | - | 4.305 | 883 | 2.345 | 10.060 |
| Shareholders Funds | - | - | - | - | - | - | 13.673 | 5.754 | 50.613 | 108.971 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 1.362 | 1.442 | 2.009 | 47.382 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Qualis Pharma S.r.l.